Literature DB >> 9099677

Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1.

B Barleon1, F Totzke, C Herzog, S Blanke, E Kremmer, G Siemeister, D Marmé, G Martiny-Baron.   

Abstract

The vascular endothelial growth factor (VEGF) receptor FLT-1 has been shown to be involved in vasculogenesis and angiogenesis. The receptor is characterized by seven Ig-like loops within the extracellular domain. Upon VEGF binding FLT-1 becomes phosphorylated, which has been thought to be preceded by receptor dimerization. To further investigate high affinity binding of VEGF to FLT-1 and ligand-induced receptor dimerization, we expressed in Sf9 cells the entire extracellular domain comprising all seven Ig-like loops: sFLT-1(7) and several truncated mutants consisting of loop one, one and two, one to three, one to four, and one to five. The corresponding proteins, named sFLT-1(1), (2), (3), (4), and (5) were purified. Only mutants sFLT-1(3) to (7) were able to bind 125I-VEGF with high affinity. No binding of VEGF was observed with sFLT-1(1) and sFLT-1(2), indicating that the first three Ig-like loops are involved in high affinity binding of VEGF. The binding of VEGF to sFLT-1(3) could be competed with placenta growth factor (PlGF), a VEGF-related ligand, suggesting that high affinity binding of VEGF and PlGF is mediated by the same or closely related contact sites on sFLT-1. Deglycosylation of the sFLT-1(3), (4), (5), and (7) did not abolish VEGF binding. Furthermore, unglycosylated sFLT-1(3), expressed in Escherichia coli, was able to bind VEGF with similar affinity as sFLT-1(3) or sFLT-1(7), both expressed in Sf9 cells. This indicates that receptor glycosylation is not essential for high affinity binding. Dimerization of the extracellular domains of FLT-1 upon addition of VEGF was detected with all mutants containing the Ig-like loop four. Although sFLT-1(3) was able to bind VEGF, dimerization of this mutant was inefficient, indicating that sites on Ig-like loop four are essential to stabilize receptor dimers.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9099677     DOI: 10.1074/jbc.272.16.10382

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

Review 1.  The impact of anti-angiogenic agents on cancer therapy.

Authors:  Dieter Marmé
Journal:  J Cancer Res Clin Oncol       Date:  2003-09-16       Impact factor: 4.553

2.  Structural basis for stem cell factor-KIT signaling and activation of class III receptor tyrosine kinases.

Authors:  Heli Liu; Xiaoyan Chen; Pamela J Focia; Xiaolin He
Journal:  EMBO J       Date:  2007-01-25       Impact factor: 11.598

3.  Cloning and expression of soluble vascular endothelial growth factors receptor-1 (sFlt-1) fragments in CHO-K1.

Authors:  Poopak Farnia; Mojgan Bandehpour; Jalaledin Ghanavi; Bahram Kazemi
Journal:  Int J Clin Exp Med       Date:  2013-09-25

4.  Spatial control of cell fate using synthetic surfaces to potentiate TGF-beta signaling.

Authors:  Lingyin Li; Joseph R Klim; Ratmir Derda; Adam H Courtney; Laura L Kiessling
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-30       Impact factor: 11.205

Review 5.  Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm?

Authors:  A R L Medford; A B Millar
Journal:  Thorax       Date:  2006-07       Impact factor: 9.139

Review 6.  Targeting extracellular domains D4 and D7 of vascular endothelial growth factor receptor 2 reveals allosteric receptor regulatory sites.

Authors:  Caroline A C Hyde; Alexandra Giese; Edward Stuttfeld; Johan Abram Saliba; Denis Villemagne; Thomas Schleier; H Kaspar Binz; Kurt Ballmer-Hofer
Journal:  Mol Cell Biol       Date:  2012-07-16       Impact factor: 4.272

7.  Direct contacts between extracellular membrane-proximal domains are required for VEGF receptor activation and cell signaling.

Authors:  Yan Yang; Peng Xie; Yarden Opatowsky; Joseph Schlessinger
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-11       Impact factor: 11.205

8.  Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies.

Authors:  Yang Gu; David F Lewis; Yuping Wang
Journal:  J Clin Endocrinol Metab       Date:  2007-10-23       Impact factor: 5.958

Review 9.  Perlecan and tumor angiogenesis.

Authors:  Xinnong Jiang; John R Couchman
Journal:  J Histochem Cytochem       Date:  2003-11       Impact factor: 2.479

10.  A compartment model of VEGF distribution in humans in the presence of soluble VEGF receptor-1 acting as a ligand trap.

Authors:  Florence T H Wu; Marianne O Stefanini; Feilim Mac Gabhann; Aleksander S Popel
Journal:  PLoS One       Date:  2009-04-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.